The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants Who Experience an Adverse Event (AE)
Timeframe: Up to approximately 9 weeks
Number of Participants Who Discontinue Study Treatment Due to an AE
Timeframe: Up to approximately 1 week